KindlyMD (NASDAQ:NAKA) Given New $0.75 Price Target at Maxim Group

KindlyMD (NASDAQ:NAKA) had its price objective lowered by Maxim Group from $1.50 to $0.75 in a report published on Monday,Benzinga reports. The brokerage currently has a buy rating on the stock.

NAKA has been the topic of a number of other research reports. B. Riley Financial reduced their price target on KindlyMD from $1.00 to $0.50 and set a “buy” rating on the stock in a research report on Monday, February 23rd. Weiss Ratings reissued a “sell (e+)” rating on shares of KindlyMD in a research report on Friday, March 27th. Two research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Hold” and an average price target of $0.63.

KindlyMD Price Performance

Shares of NASDAQ:NAKA opened at $0.22 on Monday. The company has a market capitalization of $96.20 million, a P/E ratio of -0.25 and a beta of 26.73. KindlyMD has a 1 year low of $0.21 and a 1 year high of $34.77. The business’s 50 day simple moving average is $0.27 and its 200 day simple moving average is $0.52.

Institutional Investors Weigh In On KindlyMD

A number of large investors have recently modified their holdings of the business. Alyeska Investment Group L.P. acquired a new stake in shares of KindlyMD during the 4th quarter valued at $8,993,000. ParaFi Capital LP acquired a new stake in shares of KindlyMD during the 3rd quarter valued at $443,055,000. Hunting Hill Global Capital LLC acquired a new stake in shares of KindlyMD during the 4th quarter valued at $4,672,000. RK Capital Management LLC FL acquired a new stake in shares of KindlyMD during the 3rd quarter valued at $239,052,000. Finally, Yorkville Advisors Global LP acquired a new stake in shares of KindlyMD during the 3rd quarter valued at $231,942,000.

About KindlyMD

Kindly MD, Inc (“KindlyMD” or “Kindly”) is a Utah company formed in 2019. KindlyMD is a healthcare data company, focused on holistic pain management and reducing the impact of the opioid epidemic. KindlyMD offers direct health care to patients integrating prescription medicine and behavioral health services to reduce opioid use in the chronic pain patient population. Kindly believes these methods will help prevent and reduce addiction and dependency on opiates. Our specialty outpatient clinical services are offered on a fee-for-service basis.